190 related articles for article (PubMed ID: 29450588)
41. Results of radiotherapy in 153 primary cutaneous B-Cell lymphomas classified according to the WHO-EORTC classification.
Senff NJ; Hoefnagel JJ; Neelis KJ; Vermeer MH; Noordijk EM; Willemze R;
Arch Dermatol; 2007 Dec; 143(12):1520-6. PubMed ID: 18087001
[TBL] [Abstract][Full Text] [Related]
42. Localized orbital mucosa-associated lymphoma tissue lymphoma managed with primary radiation therapy: efficacy and toxicity.
Goda JS; Le LW; Lapperriere NJ; Millar BA; Payne D; Gospodarowicz MK; Wells W; Hodgson DC; Sun A; Simpson R; Tsang RW
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e659-66. PubMed ID: 21640514
[TBL] [Abstract][Full Text] [Related]
43. Low-dose palliative radiotherapy for cutaneous B- and T-cell lymphomas.
Neelis KJ; Schimmel EC; Vermeer MH; Senff NJ; Willemze R; Noordijk EM
Int J Radiat Oncol Biol Phys; 2009 May; 74(1):154-8. PubMed ID: 18834672
[TBL] [Abstract][Full Text] [Related]
44. High rates of long-lasting remissions after 5-day bendamustine chemotherapy cycles in pre-treated low-grade non-Hodgkin's-lymphomas.
Bremer K
J Cancer Res Clin Oncol; 2002 Nov; 128(11):603-9. PubMed ID: 12458340
[TBL] [Abstract][Full Text] [Related]
45. [Radiotherapy of primary extranodal non-Hodgkin's lymphoma of the head and neck region. Results of a prospective multicenter study. Study Group NHL: early studies].
Hoederath A; Sack H; Stuschke M; Lampka E
Strahlenther Onkol; 1996 Jul; 172(7):356-66; discussion 367-8. PubMed ID: 8693402
[TBL] [Abstract][Full Text] [Related]
46. Radiotherapy alone for stage I-III low grade follicular lymphoma: long-term outcome and comparison of extended field and total nodal irradiation.
Guckenberger M; Alexandrow N; Flentje M
Radiat Oncol; 2012 Jun; 7():103. PubMed ID: 22726938
[TBL] [Abstract][Full Text] [Related]
47. Low-Dose Radiotherapy
Baron J; Wright CM; Lee DY; Carpenter M; Manjunath SH; Briceño CA; Chong E; Maity A; Plastaras JP; Paydar I
Front Oncol; 2021; 11():716002. PubMed ID: 34290991
[TBL] [Abstract][Full Text] [Related]
48. Palliation by low-dose local radiation therapy for indolent non-Hodgkin lymphoma.
Chan EK; Fung S; Gospodarowicz M; Hodgson D; Wells W; Sun A; Pintile M; Tsang RW
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):e781-6. PubMed ID: 21167657
[TBL] [Abstract][Full Text] [Related]
49. Accelerated R-COP: a pilot study for the treatment of advanced low grade lymphomas that has a high complete response rate.
Levitt MJ; Gharibo M; Strair R; Schaar D; Rubin A; Bertino JR
J Chemother; 2009 Aug; 21(4):434-8. PubMed ID: 19622463
[TBL] [Abstract][Full Text] [Related]
50. Radiotherapy for 41 patients with stages I and II MALT lymphoma: a retrospective study.
Yamashita H; Nakagawa K; Asari T; Murakami N; Igaki H; Ohtomo K
Radiother Oncol; 2008 Jun; 87(3):412-7. PubMed ID: 18423914
[TBL] [Abstract][Full Text] [Related]
51. [Role of radiotherapy in the management of non-Hodgkin lymphomas].
Gastaud L; Rossignol B; Peyrade F; Ré D; Thariat J; Thyss A; Doyen J
Cancer Radiother; 2016 May; 20(3):236-47. PubMed ID: 27133378
[TBL] [Abstract][Full Text] [Related]
52. Radiotherapy in marginal zone lymphoma.
Deinbeck K; Geinitz H; Haller B; Fakhrian K
Radiat Oncol; 2013 Jan; 8():2. PubMed ID: 23281682
[TBL] [Abstract][Full Text] [Related]
53. Dermatologic radiotherapy of primary cutaneous follicle center cell lymphoma.
Piccinno R; Caccialanza M; Berti E
Eur J Dermatol; 2003; 13(1):49-52. PubMed ID: 12609782
[TBL] [Abstract][Full Text] [Related]
54. A multicenter phase II study of local radiation therapy for stage IEA mucosa-associated lymphoid tissue lymphomas: a preliminary report from the Japan Radiation Oncology Group (JAROG).
Isobe K; Kagami Y; Higuchi K; Kodaira T; Hasegawa M; Shikama N; Nakazawa M; Fukuda I; Nihei K; Ito K; Teshima T; Matsuno Y; Oguchi M;
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1181-6. PubMed ID: 17601683
[TBL] [Abstract][Full Text] [Related]
55. Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue of the head and neck area: high rate of disease recurrence following local therapy.
Wenzel C; Fiebiger W; Dieckmann K; Formanek M; Chott A; Raderer M
Cancer; 2003 May; 97(9):2236-41. PubMed ID: 12712477
[TBL] [Abstract][Full Text] [Related]
56. Obinutuzumab plus bendamustine versus bendamustine monotherapy in patients with rituximab-refractory indolent non-Hodgkin lymphoma (GADOLIN): a randomised, controlled, open-label, multicentre, phase 3 trial.
Sehn LH; Chua N; Mayer J; Dueck G; Trněný M; Bouabdallah K; Fowler N; Delwail V; Press O; Salles G; Gribben J; Lennard A; Lugtenburg PJ; Dimier N; Wassner-Fritsch E; Fingerle-Rowson G; Cheson BD
Lancet Oncol; 2016 Aug; 17(8):1081-1093. PubMed ID: 27345636
[TBL] [Abstract][Full Text] [Related]
57. Orbital lymphoma: is it necessary to treat the entire orbit?
Pfeffer MR; Rabin T; Tsvang L; Goffman J; Rosen N; Symon Z
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):527-30. PubMed ID: 15380588
[TBL] [Abstract][Full Text] [Related]
58. Recommendations for the Optimal Radiation Dose in Patients With Primary Cutaneous Anaplastic Large Cell Lymphoma: A Report of the Dutch Cutaneous Lymphoma Group.
Melchers RC; Willemze R; Daniëls LA; Neelis KJ; Bekkenk MW; de Haas ERM; Horvath B; van Rossum MM; Sanders CJG; Velstra B; Veraart JCJM; Roach REJ; Vermeer MH; Quint KD
Int J Radiat Oncol Biol Phys; 2017 Dec; 99(5):1279-1285. PubMed ID: 28958772
[TBL] [Abstract][Full Text] [Related]
59. Favorable outcomes of radiotherapy for early-stage mucosa-associated lymphoid tissue lymphoma.
Tomita N; Kodaira T; Tachibana H; Nakamura T; Mizoguchi N; Takada A
Radiother Oncol; 2009 Feb; 90(2):231-5. PubMed ID: 19135751
[TBL] [Abstract][Full Text] [Related]
60. Radiotherapy for extranodal, marginal zone, B-cell lymphoma of mucosa-associated lymphoid tissue originating in the ocular adnexa: a multiinstitutional, retrospective review of 50 patients.
Uno T; Isobe K; Shikama N; Nishikawa A; Oguchi M; Ueno N; Itami J; Ohnishi H; Mikata A; Ito H
Cancer; 2003 Aug; 98(4):865-71. PubMed ID: 12910532
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
